Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
EXPRESSION OF CONCERN: The American Academy of Neurology's Top Five Choosing Wisely recommendations.
Inflammatory demyelinating diseases in children: an update.
Epstein-Barr virus neuraxis infection as a trigger for central nervous system demyelinating processes: a case report.
Emerging role of interleukin-22 in autoimmune diseases.
Role of vitamin D in acquired immune and autoimmune diseases.
Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis.
[Multiple sclerosis.]
Similar genetics of adult and pediatric MS: Age is just a number.
A questionnaire survey comparing the educational priorities of patients and medical students in the management of multiple sclerosis.
Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis.
MOBP-specific cellular immune responses are weaker than MOG-specific cellular immune responses in patients with multiple sclerosis and healthy subjects.
Evidence for a multiple sclerosis epidemic?
[Immunomodulatory properties of stem mesenchymal cells in autoimmune diseases.]
The prevalence of familial multiple sclerosis in saskatoon, Saskatchewan.
Mode of action and clinical studies with alemtuzumab.
[Diet and multiple sclerosis].
Few patients with neurodegenerative disorders require spinal surgery.
Lipopolysaccharide treatment arrests the cell cycle of BV-2 microglial cells in G1 phase and protects them from UV light-induced apoptosis.
Mast cells on the mind: new insights and opportunities.
Goal attainment in cognitive rehabilitation in MS patients.
EBNA2 Binds to Genomic Intervals Associated with Multiple Sclerosis and Overlaps with Vitamin D Receptor Occupancy.
Longitudinally extensive transverse myelitis in neuromyelitis optica: a prospective study of 13 Caucasian patients and literature review.
Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis.
Free radicals: properties, sources, targets, and their implication in various diseases.
Barriers and Facilitators Related to Rehabilitation Stays in Multiple Sclerosis: A Qualitative Study.
Pages
« first
‹ previous
…
375
376
377
378
379
380
381
382
383
…
next ›
last »